ESRD from lupus nephritis in the United States, 1995-2010 - Wikidata - awgldk - TriplyDB

ESRD from lupus nephritis in the United States, 1995-2010

ESRD from lupus nephritis in the United States, 1995-2010

http://www.wikidata.org/entity/Q35051164

about

Current status of lupus nephritis.Attribution of cause of end-stage renal disease among patients with systemic lupus erythematosus: the Georgia Lupus Registry Incidence of End-Stage Renal Disease Among Newly Diagnosed Systemic Lupus Erythematosus Patients: The Georgia Lupus Registry Risk factors for renal disease in systemic lupus erythematosus and their clinical implications.Severe infections in patients with lupus nephritis treated with immunosuppressants: A retrospective cohort study.Regulation of MiR-146a and TRAF6 in the Diagnose of Lupus Nephritis.Prospective validation of a novel renal activity index of lupus nephritis.Systemic lupus erythematosus.

P2860

Q33882751-0C2B042F-030C-4DAA-BCDE-36D12AAE2E4A Q36517240-DE77C307-F99C-4D3F-8290-809D4D1F75EF Q36540787-457091B5-C2F9-46F0-9AF5-DDBF1EB8B86E Q38479339-1336536D-7CE8-4533-AF4F-CC0ADD728093 Q39792182-ACE341C7-524B-4B35-91CC-C7AFCFA5A92D Q42059217-F9B89023-AB4D-4A4B-AFB4-A6E9BDEE2603 Q50745935-3B7E5EFD-ADEF-4F86-9BB5-871290343E3F Q50848358-51DAEB10-0AB0-4AB4-9695-035793B14E8C

P2860

ESRD from lupus nephritis in the United States, 1995-2010

http://www.wikidata.org/entity/Q35051164

description

2014 nî lūn-bûn

@nan

2014 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

ESRD from lupus nephritis in the United States, 1995-2010

@ast

ESRD from lupus nephritis in the United States, 1995-2010

@en

type

label

ESRD from lupus nephritis in the United States, 1995-2010

@ast

ESRD from lupus nephritis in the United States, 1995-2010

@en

prefLabel

ESRD from lupus nephritis in the United States, 1995-2010

@ast

ESRD from lupus nephritis in the United States, 1995-2010

@en

P1433

Q35051164-FF15ACD2-1A8A-4C71-AD97-B0E089D9EEA3

P1476

Q35051164-B6E67A56-768C-407C-9F87-8AEF867AC1DC

P2093

Q35051164-08173134-4FFB-4600-99B4-091C9F52B537

Q35051164-1B42869A-BCFE-4537-8770-4A85B868DD03

Q35051164-4B8CE43A-A5D3-47E1-84DE-99939066FB9F

Q35051164-757C98CD-6779-4B26-878F-F8354D22432A

Q35051164-894DD44A-CF60-4301-801F-051436BAD812

Q35051164-F842696C-30ED-4C88-BD21-624EAF75B46B

P2860

Q35051164-051337BD-3AED-4EF0-811F-81EAEB19BF9A

Q35051164-141321E6-1C48-4C60-820E-9A86C6F67B17

Q35051164-1F706585-3C94-4F0A-BFC6-9071716C79E7

Q35051164-204501E6-0284-471A-BB8C-6CAA3544835A

Q35051164-26C2492C-B5E7-4DC7-9259-3887204B4929

Q35051164-2709E876-AF1B-4E4A-B979-2BF4BDFBA7D1

Q35051164-29FA4973-EE84-4FDB-BB90-A25FDBEA66D0

Q35051164-2E993B65-11B2-4795-B781-E5DC15A30EED

Q35051164-34C214A9-4007-4A8B-B311-74E4BCC2D0C0

Q35051164-3A95684D-6E6E-4D18-BD37-C06B12BC8B71

P304

Q35051164-6A6D5075-AA3A-47EF-AA2A-B0F0D45A0872

P31

Q35051164-711864C7-0D9F-481B-875A-E4C6A65505AB

P356

Q35051164-38F4DA22-1563-4735-AFC6-3FAA0C414A67

P433

Q35051164-C2F8E780-F584-4F59-93CB-841F44FB1FCB

P478

Q35051164-14744778-90A0-49F1-9ED5-85A878A0A4F3

P577

Q35051164-C172F79B-12CA-4B6D-BD92-23C080DC281D

P698

Q35051164-ABE39CAA-F150-4DB2-89DA-533088FACE06

P932

Q35051164-86EE3A9D-C48A-40B1-BC2C-1DEE7C4F6113

P356

P1433

Clinical Journal of the American Society of Nephrology

P1476

ESRD from lupus nephritis in the United States, 1995-2010

@en

P2093

Allan J Collins

http://www.w3.org/2001/XMLSchema#string

Craig Solid

http://www.w3.org/2001/XMLSchema#string

Donal J Sexton

http://www.w3.org/2001/XMLSchema#string

Robert N Foley

http://www.w3.org/2001/XMLSchema#string

Scott Reule

http://www.w3.org/2001/XMLSchema#string

Shu-Cheng Chen

http://www.w3.org/2001/XMLSchema#string

P2860

Lupus nephritis.

Controlled trial of pulse methylprednisolone versus two regimens of pulse cyclophosphamide in severe lupus nephritis.

Population-based incidence and prevalence of systemic lupus erythematosus: the Michigan Lupus Epidemiology and Surveillance program

Azathioprine versus mycophenolate mofetil for long-term immunosuppression in lupus nephritis: results from the MAINTAIN Nephritis Trial.

Trends in the incidence, demographics, and outcomes of end-stage renal disease due to lupus nephritis in the US from 1995 to 2006.

End-stage renal disease due to lupus nephritis among children in the US, 1995-2006.

Variation in initial kidney replacement therapy for end-stage renal disease due to lupus nephritis in the United States

The incidence and prevalence of systemic lupus erythematosus, 2002-2004: The Georgia Lupus Registry.

Randomized, controlled trial of prednisone, cyclophosphamide, and cyclosporine in lupus membranous nephropathy

B-cell-depletion therapy in SLE--what are the current prospects for its acceptance?

P304

251-259

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2215/CJN.02350314

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P577

2014-12-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25534208

http://www.w3.org/2001/XMLSchema#string

P932

4317731

http://www.w3.org/2001/XMLSchema#string